Triangular Partnership with Bugando Medical Center Tansania, University of Stellenbosch, Missionsärztliches Institut Würzburg und University of Würzburg

Basic data
Continent: 
Africa
Country: 
Tanzania
Partner institution: 
Bugando Medical Center (BMC), Catholic University for Health and Allied Sciences (CUHAS), Mwanza, Tanzania;University Stellenbosch Virology, Center for Infectious diseases Stellenbosch, South Africa; Medical Mission Institute, Würzburg, Germany
City: 
Mwanza
Address: 
Bugando Medical Center, P.O Box 1370, Wuerzburg Road
Local contact: 
Dr. Samuel Kalluvya
Implementing organisation
Name of institution: 
Missionsärztliches Institut Würzburg
Department: 
Forschung und Entwicklung
Address: 
Herrmann-Schell-Str. 7
City: 
97074 Würzburg
Country: 
Germany
Local contact: 
Dr. Christa Kasang | Dr. Andreas Müller | Prof. August Stich
Phone: 
+49-931-8048518
Type of project
Aim of the project: 
Training and further education of physicians and healthcare professionals in the field of HIV, TB and other infectious diseases. Cooperative implementation of research projects
conducted since: 
2006
planned period: 
unlimited
Type: 
Medicine (clinical)
Medicine (scientific)
Epidemiology
Keywords: 
TB, HIV, co-infections, Hepatitis
Supporting organisations
International organisations: 
TB Reach
DAAD
Rexroth Foundation
Gilead Foundation
Organisations in the project country: 
NIMR Mwanza
NIMRI MMRP MBEYA
CUHAS Mwanza
BUGANDO Medical Center Mwanza
Butimba Prison, Mwanza
Staff
Number total staff: 
ca. 45
Number medical staff (Doctors only): 
ca. 25
Number non-medical staff: 
ca. 20
Research projects
Title project: 
TB-Prevalence in Tanzanian Prisons by Xpert MTB/RIF Analysis
Timeframe: 
ongoing
duration: 
2013-2015
Conference presentation: 
World Union TB Barcelona Oct 2014, OPP-443-01, TB burden in Tanzanian prisons
Title project #2: 
ProCort - Progression of HIV-Disease under Low Dose Corticosteroids
Timeframe #2: 
finished
duration #2: 
2007-2012
Conference presentation #2: 
Kasang (2014), "Effects of Prednisolone on CD4 Counts and HIV Disease Progression: A Two-Year Clinical Trial, CROI Boston
Publication #2: 
Kasang HIV patients treated with low-dose prednisolone, exhibit lower immune activation than untreated, BMC infectious disease 2012,12:14
Abstract #2: 
Background: HIV-associated general immune activation is a strong predictor for HIV disease progression,suggesting that chronic immune activation may drive HIV pathogenesis. Consequently, immunomodulating agents may decelerate HIV disease progression.Metho
Training
Possibility elective: 
Yes
Possibility scientific career (PhD, Post-Doc, German Doctor`s degree): 
Yes
Possibility for local staff for internship in implementing country: 
Yes
Additional information